semaglutide phase 1 as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Semaglutide exposure levels in STEP

Best peptides by life stage: 30s : Ipamorelin + CJC-1295 (prevention, optimization) 40s : Ipamorelin + CJC-1295 + GHK-Cu (hormone support, anti-aging) Menopause : Ipamorelin + CJC-1295 + PT-141 + Semaglutide if needed (symptom management, weight) Post-menopause : Ipamorelin + CJC-1295 + NAD+ + BPC-157 (longevity, vitality) For specific needs: Weight loss: Semaglutide + Ipamorelin Libido: PT-141 Skin: GHK-Cu Energy: NAD+ peptides Joints: BPC-157 Safety: Avoid during pregnancy/breastfeeding Excellent safety profile otherwise Can use long-term (years) Get regular blood work Cost: $250-700 monthly depending on protocol Results: Women consistently report peptides as transformative for maintaining vitality, managing menopause, achieving body composition goals, and aging well

A groundbreaking 2014 study tracked over 78,000 diabetes patients across several years to see which treatments had the biggest impact on their health when compared to non-diabetic participants

The total savings to plan sponsors and patients are estimated by various analyses at $30 billion to $100 billion annually, though estimates vary widely depending on modeling assumptions about manufacturer pricing response

10 units from a 1 mg/mL vial delivers 0.1 mg